Biopharmaceutical industry drives economic growth in all 50 states
The innovative biopharmaceutical industry has long been a significant driver of the nation’s economic growth and a key contributor to state and regional economies.
The innovative biopharmaceutical industry has long been a significant driver of the nation’s economic growth and a key contributor to state and regional economies.
The innovative biopharmaceutical industry has long been a significant driver of the nation’s economic growth and a key contributor to state and regional economies. A new report from TEConomy Partners highlights industry’s impact and reach across the country.
While the industry is a driver for the national U.S. economy, research shows that biopharmaceutical companies and their supply chains play key roles in supporting local economies and a wide range of jobs in every state across the country. In fact, nearly every state is involved in the manufacturing of FDA-approved medicines, and the biopharmaceutical industry directly employed more than 900,000 workers across the United States in 2020.
Source: TEConomy Partners data, calculations and analysis.
The report shows that industry actions in the pursuit and production of ground-breaking medical discoveries also have important benefits for state economies and workforces, including:
Source: U.S. IMPLAN Model and TEConomy estimations of 2020 Employment and Total Labor Income.
To learn more about economic impact in your state, visit our state map and read the full report.